ArticleActa clinica Croatica2024
DENGUE FEVER IN TURKEY: CASES AND PUBLIC HEALTH IMPLICATIONS.
Article in Acta clinica Croatica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue virus is endemic in almost all tropical and sub-tropical countries which also are popular tourist destinations, and it is a major international public health problem. Presented herein are six travel-associated dengue fever cases diagnosed between 2016 and 2017 in Turkey. The current situation in Turkey and in the world, as well as epidemiological data regarding the vector and relationship between the disease and traveling are also discussed. This retrospective study evaluated dengue fever cases identified using serological and molecular methods between January 2016 and February 2017 in the National Virology Reference Laboratory. Two patients had a travel history to Maldives, two patients to Thailand, one patient to Sri Lanka, and one patient to Guiana. Fever was present in all cases. The most common other symptoms were fatigue, myalgia, and arthralgia. Increased liver enzymes (50%) and thrombocytopenia (66%) were the most commonly encountered laboratory changes. In conclusion, imported dengue fever cases are increasingly reported due to facilitation of international travels and increasing commercial activities. Before traveling to a region where dengue fever is endemic, consulting a travel medicine counseling desk or a doctor is suggested. Dengue fever should be kept in mind in a patient with travel history presenting with fever, elevated liver enzyme and thrombocytopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.